Lv33
272 积分 2022-12-05 加入
Pathogenic helper T cells as the novel therapeutic targets for immune-mediated intractable diseases
13天前
已完结
7681 Real-life outcomes of biologic agents in paediatric severe asthma: a retrospective cohort study
13天前
已关闭
Targeting FAK‐YAP Signaling Axis Inhibits Tumor Stemness and Overcomes Tumor Resistance to Cuproptosis
1个月前
已完结
Toward the next generation of CAR T cell therapies for cancer
1个月前
已完结
[Analysis of COPD management in China based on health insurance data]
1个月前
已完结
Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
1个月前
已关闭
[Guidelines for the prevention and management of bronchial asthma (2024 edition)]
2个月前
已完结
Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
S1P-TREM2 axis protects immunosuppressive neutrophils from ferroptosis to promote tumour progression in hepatocellular carcinoma
2个月前
已关闭
Prognostic implication of malignant pleural metastases in stage M1a non-small cell lung cancer in a real-world Dutch cohort receiving chemotherapy and/or immunotherapy
2个月前
已完结